In the case Diamond v. Chakrabarty the court ultimately had to decide if biotech subject matter was patent-eligible. They deemed it was patent-eligible which declared “everything under the
In the case Diamond v. Chakrabarty the court ultimately had to decide if biotech subject matter was patent-eligible. They deemed it was patent-eligible which declared “everything under the